Preferential resistance of dopaminergic neurons to glutathione depletion in a reconstituted nigrostriatal system

被引:12
作者
Nakamura, K
Won, L
Heller, A
Kang, UJ
机构
[1] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA
[3] Univ Chicago, Dept Physiol & Pharmacol, Chicago, IL 60637 USA
[4] Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA
关键词
Parkinson's disease; L-buthionine-[S; R]-sulfoximine; reaggregate culture; tyrosine hydroxylase; DARPP; 32; glial fibrillary acidic protein;
D O I
10.1016/S0006-8993(00)02425-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Depletion of glutathione in the substantia nigra is one of the earliest changes observed in Parkinson's disease (PD), and could initiate dopaminergic neuronal degeneration. Nevertheless, we have previously demonstrated that mesencephalic dopaminergic neurons in primary monolayer cultures are more resistant to the toxicity of glutathione depletion than nondopaminergic neurons. To extend this finding to a system that more closely resembles the in vivo situation, we characterized the effects of glutathione depletion on reaggregate cultures derived from ventral mesencephalic and their striatal target neurons, as well as supporting elements including glia. Dopaminergic neurons were found to be more resistant to the toxicity of buthionine-(S,R)-sulfoximine, an inhibitor of glutathione synthesis, than other nigrostriatal neurons, while striatal target cells exhibited an intermediate susceptibility when examined after 48 h. Glutathione depletion, however, decreased the intracellular content of catecholamines after 48 h and eventually led to the loss of dopaminergic neurons after 7 days. Our data indicate that the intrinsic resistance of dopaminergic neurons to the toxicity of glutathione depletion occurs in a variety of experimental paradigms, and suggest that global glutathione depletion alone is unlikely to account for the selective loss of dopaminergic neurons in PD. Rather, it is more likely that either the selective loss of glutathione from dopaminergic neurons, or the combination of glutathione loss with other insults contributes to the preferential death of dopaminergic neurons in PD. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:203 / 211
页数:9
相关论文
共 46 条
[21]   Epidemiology versus generics in Parkinson's disease: Progress in resolving an age-old debate [J].
Langston, JW .
ANNALS OF NEUROLOGY, 1998, 44 (03) :S45-S52
[22]   Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: Evidence against a role for extracellular dopamine [J].
LaVoie, MJ ;
Hastings, TG .
JOURNAL OF NEUROSCIENCE, 1999, 19 (04) :1484-1491
[23]   OXYGEN-TOXICITY PROTECTING ENZYMES IN PARKINSONS-DISEASE - INCREASE OF SUPEROXIDE DISMUTASE-LIKE ACTIVITY IN THE SUBSTANTIA NIGRA AND BASAL NUCLEUS [J].
MARTTILA, RJ ;
LORENTZ, H ;
RINNE, UK .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1988, 86 (2-3) :321-331
[24]  
MULLEN RJ, 1992, DEVELOPMENT, V116, P201
[25]   Glial cells mediate toxicity in glutathione-depleted mesencephalic cultures [J].
Mytilineou, C ;
Leonardi, ETK ;
Kramer, BC ;
Jamindar, T ;
Olanow, CW .
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (01) :112-119
[26]  
Nakamura K, 1997, J NEUROCHEM, V69, P1850
[27]   Preferential resistance of dopaminergic neurons to the toxicity of glutathione depletion is independent of cellular glutathione peroxidase and is mediated by tetrahydrobiopterin [J].
Nakamura, K ;
Wright, DA ;
Wiatr, T ;
Kowlessur, D ;
Milstien, S ;
Lei, XG ;
Kang, UJ .
JOURNAL OF NEUROCHEMISTRY, 2000, 74 (06) :2305-2314
[28]   Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease [J].
Pearce, RKB ;
Owen, A ;
Daniel, S ;
Jenner, P ;
Marsden, CD .
JOURNAL OF NEURAL TRANSMISSION, 1997, 104 (6-7) :661-677
[29]   BRAIN AMINO-ACIDS AND GLUTATHIONE IN PROGRESSIVE SUPRANUCLEAR PALSY [J].
PERRY, TL ;
HANSEN, S ;
JONES, K .
NEUROLOGY, 1988, 38 (06) :943-946
[30]   IDIOPATHIC PARKINSONS-DISEASE, PROGRESSIVE SUPRANUCLEAR PALSY AND GLUTATHIONE METABOLISM IN THE SUBSTANTIA-NIGRA OF PATIENTS [J].
PERRY, TL ;
YONG, VW .
NEUROSCIENCE LETTERS, 1986, 67 (03) :269-274